Artykuł w czasopiśmie
Brak miniatury
Licencja
Dostęp zamknięty7-Methylguanosine monophosphate analogues with 5'-(1,2,3-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase
| cris.lastimport.scopus | 2024-02-12T19:31:49Z |
| dc.abstract.en | The hydrolysis of nucleoside 5'-monophosphates to the corresponding nucleosides and inorganic phosphate is catalysed by 5'-nucleotidases, thereby contributing to the control of endogenous nucleotide turnover and affecting the fate of exogenously delivered nucleotide- and nucleoside-derived therapeutics in cells. A recently identified nucleotidase cNIIIB shows preference towards 7-methylguanosine monophosphate (m7GMP) as a substrate, which suggests its potential involvement in mRNA degradation. However, the extent of biological functions and the significance of cNIIIB remains to be elucidated. Here, we synthesised a series of m7GMP analogues carrying a 1,2,3-triazole moiety at the 5' position as the potential inhibitors of human cNIIIB. The compounds were synthesised by using the copper-catalysed azide-alkyne cycloaddition (CuAAC) between 5'-azido-5'-deoxy-7-methylguanosine and different phosphate or phosphonate derivatives carrying terminal alkyne. The analogues were evaluated as cNIIIB inhibitors using HPLC and malachite green assays, demonstrating that compound 1a, carrying a 1,2,3-triazoylphosphonate moiety, inhibits cNIIIB activity at micromolar concentrations (IC50 87.8 ± 7.5 µM), while other analogues showed no activity. In addition, compound 1d was identified as an artifical substrate for HscNIIIB. Further characterization of inhibitor 1a revealed that it is poorly recognised by other m7G-binding proteins, eIF4E and DcpS, indicating its selectivity towards cNIIIB. The first inhibitor (1a) and unnatural substrate (1d) of cNIIIB, identified here, can be used as molecular probes for the elucidation of biological roles of cNIIIB, including the verification of its proposed function in mRNA metabolism. |
| dc.affiliation | Uniwersytet Warszawski |
| dc.contributor.author | Kubacka, Dorota |
| dc.contributor.author | Wojtczak, Błażej |
| dc.contributor.author | Baranowski, Marek |
| dc.contributor.author | Kowalska, Joanna |
| dc.contributor.author | Kasprzyk, Renata |
| dc.contributor.author | Kozarski, Mateusz |
| dc.date.accessioned | 2024-01-24T15:36:23Z |
| dc.date.available | 2024-01-24T15:36:23Z |
| dc.date.issued | 2018 |
| dc.description.finance | Nie dotyczy |
| dc.identifier.doi | 10.1016/J.BMC.2017.11.032 |
| dc.identifier.issn | 0968-0896 |
| dc.identifier.uri | https://repozytorium.uw.edu.pl//handle/item/100098 |
| dc.language | eng |
| dc.pbn.affiliation | chemical sciences |
| dc.relation.ispartof | Bioorganic and Medicinal Chemistry |
| dc.rights | ClosedAccess |
| dc.sciencecloud | nosend |
| dc.subject.en | 5′ Nucleotidase cNIIIB |
| dc.subject.en | 7-Methylguanosine 5′-monophosphate |
| dc.subject.en | Click chemistry |
| dc.subject.en | Enzyme inhibitor |
| dc.subject.en | mRNA cap |
| dc.subject.en | mRNA degradation |
| dc.title | 7-Methylguanosine monophosphate analogues with 5'-(1,2,3-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase |
| dc.type | JournalArticle |
| dspace.entity.type | Publication |